LNSR
LNSR
NASDAQ · Health Care

Lensar Inc

$5.00
+0.30 (+6.38%)
As of Nov 14, 10:37 PM ET ·
Financial Highlights (FY 2026)
Revenue
63.91M
Net Income
-37,493,510
Gross Margin
46.4%
Profit Margin
-58.7%
Rev Growth
+18.2%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 46.4% 46.4% 57.4% 57.4%
Operating Margin -42.1% -37.9% 10.3% 10.3%
Profit Margin -58.7% -55.7% 9.6% 8.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 63.91M 54.06M 55.38M 51.89M
Gross Profit 29.66M 25.09M 31.77M 29.77M
Operating Income -26,881,827 -20,463,202 5.73M 5.35M
Net Income -37,493,510 -28,541,113 5.32M 4.60M
Gross Margin 46.4% 46.4% 57.4% 57.4%
Operating Margin -42.1% -37.9% 10.3% 10.3%
Profit Margin -58.7% -55.7% 9.6% 8.9%
Rev Growth +18.2% +18.2% +8.2% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 15.51M 16.29M
Total Equity — — 70.64M 78.05M
D/E Ratio — — 0.22 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -25,874,144 -20,790,355 9.24M 7.86M
Free Cash Flow — — 5.04M 4.51M